UPDATE
1-MOVES-Pershing Square?s Valeant analyst to
exit, Ackman sees stock rising
BOSTON, Aug 26 (Reuters) - Billionaire investor WilliamAckman said on Friday that Jordan Rubin, who had worked closelyon Pershing Square Capital Management's controversial investmentin battered drug maker
Valeant Pharmaceuticals, is leaving thehedge fund.